Biogen Idec +5% in premarket following positve developments on Alzheimer's drug BIIB037 at Deutsche Bank BIOFEST
BIIB is +5% premarket after co presented positive phase 1b data on its Alzheimer's drug BIIB037 at Deutsche Bank BIOFEST; co plans to start phase 3 program.